UBS Group’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.6K | Sell |
|
|||||
|
2025
Q1 | $64.4K | Sell |
|
|||||
|
2024
Q4 | $390K | Buy |
|
|||||
|
2024
Q3 | $30.5K | Sell |
|
|||||
|
2024
Q2 | $67K | Buy |
|
|||||
|
2024
Q1 | $25K | Buy |
|
|||||
|
2023
Q4 | $601 | Sell |
|
|||||
|
2023
Q3 | $7.85K | Buy |
|
|||||
|
2023
Q2 | $219 | Sell |
|
|||||
|
2023
Q1 | $24.7K | Buy |
|
|||||
|
2022
Q4 | $18.3K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $21K | Buy |
|
|||||
|
2022
Q1 | $16K | Sell |
|
|||||
|
2021
Q4 | $871K | Buy |
|
|||||
|
2021
Q3 | $585K | Buy |
|
|||||
|
2021
Q2 | $1K | Sell |
|
|||||
|
2021
Q1 | $23K | Sell |
|
|||||
|
2020
Q4 | $39K | Sell |
|
|||||
|
2020
Q3 | $14K | Sell |
|
|||||
|
2020
Q2 | $41K | Buy |
|
|||||
|
2020
Q1 | $13K | Buy |
|
|||||
|
2019
Q4 | $14K | Sell |
|
|||||
|
2019
Q3 | $27K | Buy |
|
|||||
|
2019
Q2 | $11K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $13K | Sell |
|
|||||
|
2018
Q3 | $16K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $12K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $0 | Sell |
|
|||||
|
2017
Q2 | $11K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $4K | Buy |
|
|||||
|
2016
Q3 | $3K | Buy |
|